Big news from FDA and Medicare! First treatment approved to reduce cardiovascular risk in obesity & cardiac patients. Plus, Medicare has allowed access to Wegovy for those with part D. We are thrilled to witness advancements in #obesitymedicine! #semaglutide #wegovy #weightlossmedications
Obesity Medicine ABOM Diplomate | Physician Nutritionist Specialist | Internal Medicine | Board Certified
It’s official. FDA approves first treatment to reduce risk for cardiovascular events for those suffering from #obesity and has #cardiac disease. Medicare also announced last week allowing access to Wegovy for those with part D. Exciting times in the practice of #obesitymedicine! #lindoraclinic #metabolichealth #semaglutide
